+185.0%
ASTS vs GSK
+42.5%
+142.5%
-85.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +8.7% | -1.2% | +9.9% | +8.7% |
| 7D | +2.8% | -1.1% | +3.9% | +2.8% |
| 30D | -28.8% | +7.8% | -36.7% | -28.9% |
| 3M | -48.9% | +0.3% | -49.2% | -48.8% |
| 6M | -55.6% | +3.4% | -59.1% | -55.6% |
| YTD | -49.6% | +5.9% | -55.5% | -49.5% |
| 1Y | -46.1% | +8.2% | -54.3% | -46.0% |
| 3Y | +749.7% | +65.3% | +684.4% | +746.7% |
| All | +185.0% | +42.5% | +142.5% | +165.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling